KENNABAMINE

Serial Number 98025453
688

Registration Progress

Application Filed
Jun 2, 2023
Under Examination
Aug 26, 2025
Approved for Publication
Jul 1, 2025
Published for Opposition
Jul 1, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Feb 26, 2026 57 days

Trademark Image

KENNABAMINE

Basic Information

Serial Number
98025453
Filing Date
June 2, 2023
Published for Opposition
July 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Aug 26, 2025
Application
Pending
Classes
005

Rights Holder

Progressive Therapeutics, Inc.

03
Address
32 Monument Road
Orleans, MA 02653

Ownership History

Progressive Therapeutics, Inc.

Original Applicant
03
Orleans, MA

Progressive Therapeutics, Inc.

Owner at Publication
03
Orleans, MA

Legal Representation

Attorney
Jeffrey J. Ellison

USPTO Deadlines

Next Deadline
57 days remaining
NOA E-Mailed - SOU Required
Due Date
February 26, 2026
Extension Available
Until August 26, 2026

Application History

18 events
Date Code Type Description Documents
Aug 26, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 1, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 25, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 30, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 30, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 30, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 30, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 22, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 22, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 22, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 26, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 7, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Preparations for the treatment of anxiety and depression containing cannabis ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) content of not more than 0.3 percent on a dry weight basis, and not containing cannabidiol (CBD)

Classification

International Classes
005